Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008664022> ?p ?o ?g. }
- W2008664022 endingPage "1307" @default.
- W2008664022 startingPage "1303" @default.
- W2008664022 abstract "Abstract Objectives Recent investigations on the pharmacokinetics of levodopa (l-dopa) indicated that the presence of Helicobacter pylori in patients with Parkinson's disease, orally treated with l-dopa, influences the absorption of this compound, which consequently leads to decreased plasma levels. Therefore this work aims to study a potential in-vitro interaction of l-dopa with H. pylori and its surface adhesins. Methods Solutions containing l-dopa of different concentrations were incubated with H. pylori at different bacterial densities and time intervals. Free l-dopa was quantified from the incubation supernatants by HPLC. A flow cytometric assay with fluorescence labelled H. pylori was used to investigate the influence of l-dopa on the bacterial adhesion of H. pylori: FITC-labelled bacteria were pre-incubated with l-dopa, followed by incubation with gastric epithelial cells (AGS cells) and FACS quantification of adhering bacteria. Key findings Evaluation of time- and concentration-dependent incubation experiments indicated a significant decrease in l-dopa concentrations when coming into contact with H. pylori. The reduction in l-dopa concentrations was determined as 47 to 12%, referred to the initial starting concentration, with time-dependency and dependency of the H. pylori density. FITC-labelled H. pylori, pre-incubated with differing l-dopa concentrations, were shown to have a significantly reduced bacterial adhesion to AGS cells, with a maximum reduction of 22 ± 9%. These results demonstrate a direct interaction of l-dopa with the outer membrane proteins of H. pylori responsible for the adhesion to gastric epithelial cells. By this interaction the unbound l-dopa concentration in bacterial suspension was strongly reduced. Conclusions This study suggests a potential in-vitro interaction of l-dopa with H. pylori adhesins, confirming the clinical changes found in pharmacokinetics of l-dopa therapy by H. pylori-positive patients with Parkinson's disease." @default.
- W2008664022 created "2016-06-24" @default.
- W2008664022 creator A5085040154 @default.
- W2008664022 creator A5086288750 @default.
- W2008664022 date "2009-10-01" @default.
- W2008664022 modified "2023-09-27" @default.
- W2008664022 title "In-vitro interaction of <scp>l</scp>-dopa with bacterial adhesins of <i>Helicobacter pylori:</i> an explanation for clinicial differences in bioavailability?" @default.
- W2008664022 cites W1510180387 @default.
- W2008664022 cites W1968614108 @default.
- W2008664022 cites W1970631135 @default.
- W2008664022 cites W2030336958 @default.
- W2008664022 cites W2039088059 @default.
- W2008664022 cites W2043540762 @default.
- W2008664022 cites W2058978070 @default.
- W2008664022 cites W2059337001 @default.
- W2008664022 cites W2060732617 @default.
- W2008664022 cites W2081688565 @default.
- W2008664022 cites W2083533871 @default.
- W2008664022 cites W2088957649 @default.
- W2008664022 cites W2095889210 @default.
- W2008664022 cites W2096536107 @default.
- W2008664022 cites W2099007595 @default.
- W2008664022 cites W2109288088 @default.
- W2008664022 cites W2110132014 @default.
- W2008664022 cites W2112940088 @default.
- W2008664022 cites W2113739192 @default.
- W2008664022 cites W2140091288 @default.
- W2008664022 cites W2143266772 @default.
- W2008664022 cites W2153419053 @default.
- W2008664022 doi "https://doi.org/10.1211/jpp.61.10.0005" @default.
- W2008664022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19814861" @default.
- W2008664022 hasPublicationYear "2009" @default.
- W2008664022 type Work @default.
- W2008664022 sameAs 2008664022 @default.
- W2008664022 citedByCount "27" @default.
- W2008664022 countsByYear W20086640222012 @default.
- W2008664022 countsByYear W20086640222013 @default.
- W2008664022 countsByYear W20086640222014 @default.
- W2008664022 countsByYear W20086640222016 @default.
- W2008664022 countsByYear W20086640222017 @default.
- W2008664022 countsByYear W20086640222018 @default.
- W2008664022 countsByYear W20086640222019 @default.
- W2008664022 countsByYear W20086640222020 @default.
- W2008664022 countsByYear W20086640222021 @default.
- W2008664022 countsByYear W20086640222022 @default.
- W2008664022 countsByYear W20086640222023 @default.
- W2008664022 crossrefType "journal-article" @default.
- W2008664022 hasAuthorship W2008664022A5085040154 @default.
- W2008664022 hasAuthorship W2008664022A5086288750 @default.
- W2008664022 hasConcept C104317684 @default.
- W2008664022 hasConcept C121332964 @default.
- W2008664022 hasConcept C125287762 @default.
- W2008664022 hasConcept C143701427 @default.
- W2008664022 hasConcept C150903083 @default.
- W2008664022 hasConcept C178790620 @default.
- W2008664022 hasConcept C179470777 @default.
- W2008664022 hasConcept C181389837 @default.
- W2008664022 hasConcept C185592680 @default.
- W2008664022 hasConcept C202751555 @default.
- W2008664022 hasConcept C207001950 @default.
- W2008664022 hasConcept C24890656 @default.
- W2008664022 hasConcept C25642318 @default.
- W2008664022 hasConcept C2776409635 @default.
- W2008664022 hasConcept C523546767 @default.
- W2008664022 hasConcept C54355233 @default.
- W2008664022 hasConcept C547475151 @default.
- W2008664022 hasConcept C55493867 @default.
- W2008664022 hasConcept C84416704 @default.
- W2008664022 hasConcept C86803240 @default.
- W2008664022 hasConcept C89423630 @default.
- W2008664022 hasConcept C98274493 @default.
- W2008664022 hasConceptScore W2008664022C104317684 @default.
- W2008664022 hasConceptScore W2008664022C121332964 @default.
- W2008664022 hasConceptScore W2008664022C125287762 @default.
- W2008664022 hasConceptScore W2008664022C143701427 @default.
- W2008664022 hasConceptScore W2008664022C150903083 @default.
- W2008664022 hasConceptScore W2008664022C178790620 @default.
- W2008664022 hasConceptScore W2008664022C179470777 @default.
- W2008664022 hasConceptScore W2008664022C181389837 @default.
- W2008664022 hasConceptScore W2008664022C185592680 @default.
- W2008664022 hasConceptScore W2008664022C202751555 @default.
- W2008664022 hasConceptScore W2008664022C207001950 @default.
- W2008664022 hasConceptScore W2008664022C24890656 @default.
- W2008664022 hasConceptScore W2008664022C25642318 @default.
- W2008664022 hasConceptScore W2008664022C2776409635 @default.
- W2008664022 hasConceptScore W2008664022C523546767 @default.
- W2008664022 hasConceptScore W2008664022C54355233 @default.
- W2008664022 hasConceptScore W2008664022C547475151 @default.
- W2008664022 hasConceptScore W2008664022C55493867 @default.
- W2008664022 hasConceptScore W2008664022C84416704 @default.
- W2008664022 hasConceptScore W2008664022C86803240 @default.
- W2008664022 hasConceptScore W2008664022C89423630 @default.
- W2008664022 hasConceptScore W2008664022C98274493 @default.
- W2008664022 hasIssue "10" @default.
- W2008664022 hasLocation W20086640221 @default.
- W2008664022 hasOpenAccess W2008664022 @default.
- W2008664022 hasPrimaryLocation W20086640221 @default.
- W2008664022 hasRelatedWork W1965016416 @default.